All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

BB BIOTECH AG BB BIOTECH ORD SH revenue reports

BB BIOTECH AG BB BIOTECH ORD SH financial reports, BB BIOTECH AG BB BIOTECH ORD SH annual revenue in 2024. When does BB BIOTECH AG BB BIOTECH ORD SH report revenue?
Add to widgets
Added to widgets

BB BIOTECH AG BB BIOTECH ORD SH total revenue, net income and dynamics of changes in Swiss franc today

Net revenue of BB BIOTECH AG BB BIOTECH ORD SH on 30/06/2021 amounted to 144 258 000 Fr. The dynamics of net revenue of BB BIOTECH AG BB BIOTECH ORD SH decreased. The change amounted to -91 297 000 Fr. The dynamics of net revenue is shown in comparison with the previous report. Net income, revenue and dynamics - the main financial indicators of BB BIOTECH AG BB BIOTECH ORD SH. Chart of online financial report of BB BIOTECH AG BB BIOTECH ORD SH. The financial graph of BB BIOTECH AG BB BIOTECH ORD SH shows the values and changes of such indicators: total assets, net income, net revenue. The financial report schedule from 31/12/2018 to 30/06/2021 is available online.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 131 139 754.51 Fr - 116 857 450.01 Fr -
31/03/2021 214 134 570.52 Fr -59.308 % ↓ 200 855 872.67 Fr -75.168 % ↓
31/12/2020 617 988 979.71 Fr - 604 241 204.84 Fr -
30/09/2020 0 Fr -100 % ↓ -359 277 546.89 Fr -
30/09/2019 186 358.12 Fr - -347 049 727.02 Fr -
30/06/2019 -336 305 499.61 Fr - -305 268 236.52 Fr -
31/03/2019 526 226 241.42 Fr - 808 867 874.98 Fr -
31/12/2018 -185 125 429.22 Fr - -584 394 519.59 Fr -
Show:
to

BB BIOTECH AG BB BIOTECH ORD SH financial report charts

Dates of BB BIOTECH AG BB BIOTECH ORD SH finance reports: 31/12/2018, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of BB BIOTECH AG BB BIOTECH ORD SH is available online for such a date - 30/06/2021. Gross profit BB BIOTECH AG BB BIOTECH ORD SH is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit BB BIOTECH AG BB BIOTECH ORD SH is 144 258 000 Fr

BB BIOTECH AG BB BIOTECH ORD SH quarterly report dates

Total revenue BB BIOTECH AG BB BIOTECH ORD SH refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue BB BIOTECH AG BB BIOTECH ORD SH is 144 258 000 Fr Operating income BB BIOTECH AG BB BIOTECH ORD SH is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income BB BIOTECH AG BB BIOTECH ORD SH is 129 601 000 Fr Net income BB BIOTECH AG BB BIOTECH ORD SH is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income BB BIOTECH AG BB BIOTECH ORD SH is 128 547 000 Fr

Current assets BB BIOTECH AG BB BIOTECH ORD SH is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets BB BIOTECH AG BB BIOTECH ORD SH is 4 357 070 000 Fr Total assets BB BIOTECH AG BB BIOTECH ORD SH refers to the total amount of assets owned by a person or entity. Total assets BB BIOTECH AG BB BIOTECH ORD SH is 4 357 070 000 Fr Current cash BB BIOTECH AG BB BIOTECH ORD SH - the sum of all of the cash a company has on the date of report. Current cash BB BIOTECH AG BB BIOTECH ORD SH is 3 174 000 Fr

30/06/2021 31/03/2021 31/12/2020 30/09/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
131 139 754.51 Fr 214 134 570.52 Fr 617 988 979.71 Fr - 186 358.12 Fr -336 305 499.61 Fr 526 226 241.42 Fr -185 125 429.22 Fr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
131 139 754.51 Fr 214 134 570.52 Fr 617 988 979.71 Fr - 186 358.12 Fr -336 305 499.61 Fr 526 226 241.42 Fr -185 125 429.22 Fr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
117 815 603.46 Fr 200 724 058.39 Fr 605 742 978.57 Fr -10 708 773.92 Fr -10 126 972.96 Fr -347 094 271.16 Fr 514 942 029.99 Fr -195 451 487.19 Fr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
116 857 450.01 Fr 200 855 872.67 Fr 604 241 204.84 Fr -359 277 546.89 Fr -347 049 727.02 Fr -305 268 236.52 Fr 808 867 874.98 Fr -584 394 519.59 Fr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
13 324 151.05 Fr 13 410 512.13 Fr 12 246 001.14 Fr 10 708 773.92 Fr 10 313 331.08 Fr 10 788 771.55 Fr 11 284 211.43 Fr 10 326 057.98 Fr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
3 960 855 482.48 Fr 3 893 445 659.69 Fr 3 602 743 355.64 Fr 3 164 031 796.43 Fr 2 940 265 692.83 Fr 3 313 215 562.28 Fr 3 624 858 155.57 Fr 2 806 138 754.02 Fr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
3 960 855 482.48 Fr 3 893 445 659.69 Fr 3 602 743 355.64 Fr 3 164 031 796.43 Fr 2 940 265 692.83 Fr 3 313 215 562.28 Fr 3 624 858 155.57 Fr 2 806 138 754.02 Fr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
2 885 369.14 Fr 3 558 076.50 Fr 6 196 180.22 Fr 13 529 599.51 Fr 8 566 110.07 Fr 7 996 126.94 Fr 7 642 501.05 Fr 20 064 860.61 Fr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 315 114 308.70 Fr 341 014 451.13 Fr 347 388 807.90 Fr 183 932 737.25 Fr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 315 114 308.70 Fr 341 014 451.13 Fr 347 388 807.90 Fr 183 932 737.25 Fr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 10.72 % 10.29 % 9.58 % 6.55 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 678 982 008 Fr 3 562 124 557.99 Fr 3 534 029 026.01 Fr 2 937 278 508.53 Fr 2 625 151 384.13 Fr 2 972 201 111.15 Fr 3 277 469 347.67 Fr 2 622 206 016.77 Fr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 28 035 533.76 Fr 5 511 655.03 Fr -31 221 803.08 Fr 138 759 528.96 Fr

Last revenue report of BB BIOTECH AG BB BIOTECH ORD SH was 30/06/2021. According to last financial report total revenue in BB BIOTECH AG BB BIOTECH ORD SH was 131 139 754.51 Swiss franc and changed by -59.308% since last year. Net income in BB BIOTECH AG BB BIOTECH ORD SH was 116 857 450.01 Fr in last quartal, net income changes to -75.168%.

BB BIOTECH AG BB BIOTECH ORD SH stocks data

BB BIOTECH AG BB BIOTECH ORD SH financials